Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMRN | AMGN | VRTX | BMY | GILD |
| Company | Amarin Corp ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.5000 | 282.08 | 467.48 | 59.40 | 92.53 |
| High | 0.5067 | 282.39 | 468.19 | 59.51 | 93.87 |
| Low | 0.4920 | 276.93 | 463.05 | 58.92 | 92.49 |
| Last | 0.4993 | 278.62 | 465.82 | 59.54 | 93.76 |
| Change | -0.0074 | -4.25 | -2.31 | +0.32 | +1.18 |
| % Change | -1.46% | -1.50% | -0.49% | +0.54% | +1.27% |
| Volume | 446,156 | 1,488,100 | 221,865 | 2,368,314 | 1,516,842 |
| 20-Day Average Volume | 1,367,908 | 4,086,166 | 1,384,196 | 11,264,428 | 7,221,040 |
| Previous Close | 0.5067 | 282.87 | 468.13 | 59.22 | 92.58 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5361 | 297.67 | 475.79 | 57.65 | 91.80 |
| 20-Day Raw Stochastic | 22.82% | 29.45% | 26.97% | 77.22% | 58.93% |
| 20-Day Relative Strength | 41.60% | 33.93% | 46.99% | 63.36% | 61.88% |
| Weighted Alpha | -52.93 | -4.43 | +23.62 | +28.05 | +28.65 |
| Today's Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 96% Sell | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.19% since 11/22/24 | -5.43% since 11/22/24 | +3.15% since 11/22/24 | +1.00% since 11/22/24 | +3.82% since 11/22/24 |
| Low | 0.4802 on 11/29/24 | 257.80 on 11/26/24 | 455.83 on 11/25/24 | 58.06 on 11/26/24 | 89.50 on 11/25/24 |
| High | 0.5500 on 11/25/24 | 297.32 on 11/25/24 | 470.93 on 11/29/24 | 60.68 on 11/25/24 | 93.64 on 12/02/24 |
| 1-Month | |||||
| %Chg | -15.01% since 11/01/24 | -12.74% since 11/01/24 | -1.26% since 11/01/24 | +9.46% since 11/01/24 | +4.61% since 11/01/24 |
| Low | 0.4565 on 11/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 53.97 on 11/08/24 | 86.08 on 11/19/24 |
| High | 0.6392 on 11/06/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -20.35% since 08/30/24 | -16.56% since 08/30/24 | -6.19% since 08/30/24 | +19.04% since 08/30/24 | +18.53% since 08/30/24 |
| Low | 0.4565 on 11/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 77.74 on 09/05/24 |
| High | 0.6641 on 10/29/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -42.40% since 05/31/24 | -8.93% since 05/31/24 | +2.16% since 05/31/24 | +44.71% since 05/31/24 | +45.69% since 05/31/24 |
| Low | 0.4565 on 11/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 62.69 on 06/18/24 |
| High | 0.8790 on 06/03/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 208,088 | 152,051,968 | 120,557,048 | 120,108,640 | 115,379,312 |
| Shares Outstanding, K | 410,672 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 306,910,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -59,110,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 42,300,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -25,130,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.92 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 10/30/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/30/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 0.00 | 50.66 | 20.86 |